User:Daedalus51/sandbox

"No vaccine for Hepatitis C exists".

I spotted an article in the Boston Globe about the financial losses to Partner HealthCare. A unit of the firm incurred most losses from claims for a new treatment of Hepatitis C by Gilead Science. I left the source below. Right now it costs $1000 a pill & $84,000 for the treatment. It's apparently known as Sovaldi. FiercePHarma wrote:

"In a letter sent yesterday to the House Committee on Energy and Commerce, Representatives Henry Waxman (D-CA) and Diana DeGette (D-CO) expressed concern that Sovaldi (sofosbuvir) will be too big a drain on Medicare. They cited new research from Georgetown University and the Kaiser Family Foundation that found that Sovaldi will increase Medicare Part D drug spending by as much as $6.5 billion in 2015 alone. That would cause overall Medicare drug spending to rise by 8%".

Gilead Sciences won't budge over the price but protests are increasing. FiercePharma reported that "the U.K.'s National Institute for Health and Care Excellence (NICE) said that it's leaning toward not recommending Sovaldi for routine use until Gilead provides more complete evidence of the drug's effectiveness, particularly in certain subgroups of patients with hepatitis C. A final decision is expected in October".

Read more: Why does Sovaldi cost $84,000? Gilead Sciences being pressed hard for an answer - FiercePharma http://www.fiercepharma.com/story/why-does-sovaldi-cost-84000-gilead-sciences-being-pressed-hard-answer/2014-06-20#ixzz35P6VPagk Subscribe at FiercePharma

http://www.bostonglobe.com/business/2014/05/09/partners-income-tumbles-insurance-losses-erode-gain-from-hospital-operations/wPQSv40emFQxJ7zvBRi0NM/story.html#

http://www.fiercepharma.com/story/why-does-sovaldi-cost-84000-gilead-sciences-being-pressed-hard-answer/2014-06-20